References
- Advisory Council on the Misuse of Drugs. (2000). Reducing Drug Related Deaths: A Report of the Advisory Council on the Misuse of Drugs. London: Stationery Office
- Anthony, G. B., Matheson, C. I., Holland, R., Bond, C., Roberts, K., MacRae, A, Whitelaw, E., & Priyadarshi, S. (2011). Methadone prescribing under supervised consumption on premises: A Scottish clinician's perspective on prescribing practice. Drug and Alcohol Review, 31, 342–347
- Bell, J., Shanahan, M., Mutch, C., Rea, F., Ryan, A., Batey, R., Dunlop, A., & Winstock, A. (2007). A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. Addiction, 102, 1899–1907
- Cameron, I., Naji, S., Lind, C., & McKeganey, N. (2002). Effective Interventions Unit: A Survey of NHS Services for Opiate Dependents in Scotland. Edinburgh: Scottish Executive
- Department of Health (England) and the Devolved Administrations. (2007). Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive
- Gerra, G., Saenz, E., Busse, A., Maremmani, I., Ciccocioppo, R., Zaimovic, A., Gerra, M. L., Amore, M., Manfredini, M.,Donnin, C., & Somaini, L. (2011). Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 483–489
- Holland, R., Matheson, C., Anthony, G., Roberts, K., Priyadarshi, S., MacRae, A., Whitelaw, E., Appavoo, S., & Bond, C. (2012). A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol Review, 31, 483–491
- Matheson, C., Bond, C. M., & Tinelli, M. (2007). Community pharmacy harm reduction services for drug misusers: National service delivery and professional attitude development over a decade in Scotland. Journal of Public Health, 29, 350–357
- Meehan, W. J. (2010). Opioid Abuse: Overview [Online]. Available from: http://emedicine.medscape.com/article/287790-overview [last accessed 3 April 2010]
- National Institute for Health and Clinical Excellence. (2007). Methadone and Buprenorphine for the Management of Opioid Dependence – NICE Technology Appraisal 114. London: Methadone and Buprenorphine for the Management of Opioid Dependence
- Neale, J. (1999). Drug users' views of substitute prescribing conditions. International Journal of Drug Policy, 10, 247–258
- Rhoades, H. M., Creson, D., Elk, R., Schmitz, J., & Grabowski, J. (1998). Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency. American Journal of Public Health, 88, 34–39
- Roberts, K., McNulty, H., Gruer, L., Scott, R., & Bryson, S. (1998). The role of Glasgow pharmacists in the management of drug misuse. International Journal of Drug Policy, 9, 187–194
- Silverman, K., Wong, C. J., Higgins, S. T., Brooner, R. K., Montoya, I. D., Contoreggi, C., Umbricht-Schneiter, A., Schuster, C. R., & Preston, K. L. (1996). Increasing opiate abstinence through voucher-based reinforcement therapy. Drug and Alcohol Dependence, 41, 157–165
- Strang, J., Manning, V., Mayet, S., Ridge, G., Best, D., & Sheridan, J. (2007). Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995–2005. Addiction, 102, 761–770
- Weaver, T., Hart, J., Fehler, J., Metrebian, N., D’Agostino, T. & Benn, P. (2007). Are Contingency Management Principles Being Implemented in Drug Treatment in England? London: National Treatment Agency for Substance Misuse